Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Capital Reinvestment Ratio
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Capital Reinvestment Ratio of 1.07x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥15.48 Million) in capital expenditures (CN¥16.52 Million). Check 002099 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Hisoar Pharmaceutical Co Ltd Capital Reinvestment Ratio (2004–2024)
This chart tracks Zhejiang Hisoar Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 21 annual periods. For the full cash flow conversion analysis, see Zhejiang Hisoar Pharmaceutical Co Ltd (002099) cash conversion ratio.
Annual Capital Reinvestment Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd from 2004 to 2024. See Zhejiang Hisoar Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.70x | CN¥174.83 Million | CN¥122.11 Million | ▲ +9.7% |
| 2023 | 0.64x | CN¥240.54 Million | CN¥153.08 Million | ▼ -58.8% |
| 2022 | 1.55x | CN¥116.09 Million | CN¥179.42 Million | ▼ -31.1% |
| 2021 | 2.24x | CN¥102.36 Million | CN¥229.56 Million | ▲ +1514.0% |
| 2020 | 0.14x | CN¥533.87 Million | CN¥74.18 Million | ▼ -47.0% |
| 2019 | 0.26x | CN¥612.40 Million | CN¥160.64 Million | ▼ -18.8% |
| 2018 | 0.32x | CN¥791.45 Million | CN¥255.78 Million | ▼ -77.7% |
| 2017 | 1.45x | CN¥102.68 Million | CN¥148.99 Million | ▲ +634.7% |
| 2016 | 0.20x | CN¥629.42 Million | CN¥124.31 Million | ▼ -69.2% |
| 2015 | 0.64x | CN¥462.16 Million | CN¥296.36 Million | ▼ -27.3% |
| 2014 | 0.88x | CN¥191.56 Million | CN¥169.06 Million | ▼ -80.9% |
| 2013 | 4.63x | CN¥60.85 Million | CN¥281.79 Million | ▲ +96.1% |
| 2012 | 2.36x | CN¥180.73 Million | CN¥426.79 Million | ▲ +0.5% |
| 2011 | 2.35x | CN¥92.62 Million | CN¥217.52 Million | ▲ +190.0% |
| 2010 | 0.81x | CN¥180.88 Million | CN¥146.51 Million | ▲ +48.7% |
| 2009 | 0.54x | CN¥98.38 Million | CN¥53.60 Million | ▼ -81.6% |
| 2008 | 2.95x | CN¥30.61 Million | CN¥90.40 Million | ▲ +34.1% |
| 2007 | 2.20x | CN¥51.14 Million | CN¥112.61 Million | ▲ +32.8% |
| 2006 | 1.66x | CN¥61.88 Million | CN¥102.59 Million | ▼ -18.9% |
| 2005 | 2.04x | CN¥36.07 Million | CN¥73.74 Million | ▲ +103.6% |
| 2004 | 1.00x | CN¥42.36 Million | CN¥42.54 Million | — |